Pediatric Tumor Board: Gliomatosis Cerebri

Statement of Need/Program Overview
Although it has been 10 years since gliomatosis cerebri was removed as an independent diagnosis by WHO, it remains a challenging clinical entity as a manifestation and growth pattern of multiple glioma subtypes, as well as a subject of continued scientific investigation. In this webinar, we will review diverse cases of gliomatosis cerebri and discuss how evolving understanding is informing multidisciplinary treatment and management of this complex entity.

Educational Objectives 
After participating in this CME activity, participants should be able to:

• Identify the range of clinical and imaging manifestations of gliomatosis cerebri. 
• Discuss the range of glioma subtypes that can manifest as gliomatosis cerebri. 
• Develop treatment and management plans for gliomatosis cerebri across diverse clinical situations.